Notably, we observed a significantly lower rate of underestimation with VAB than with CCNB; specifically, our DCIS underestimation rate with 13-G VAB (7.7%) was lower than the rates in previous reports with 11-G VAB (17%–41%). This evidence concerns the gene CCNB1 and ductal breast carcinoma in situ.